Attention-Deficit/Hyperactivity Disorder and Very Preterm/Very Low Birth Weight: A Meta-analysis

Imagem de Miniatura
Arquivos
art_FRANZ_AttentionDeficitHyperactivity_Disorder_and_Very_PretermVery_Low_Birth_Weight_2018.PDF (1.44 MB)
Citações na Scopus
184
Tipo de produção
article
Data de publicação
2018
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
AMER ACAD PEDIATRICS
Autores
FRANZ, Adelar Pedro
BOLAT, Gul Unsel
BOLAT, Hilmi
SANTOS, Ina Silva
SILVEIRA, Rita C.
PROCIANOY, Renato Soibelmann
ROHDE, Luis Augusto
MOREIRA-MAIA, Carlos Renato
Citação
PEDIATRICS, v.141, n.1, article ID e20171645, 16p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
CONTEXT: Although very preterm (VP), extremely preterm (EP), very low birth weight (VLBW), and extremely low birth weight (ELBW) newborns seem to have a higher risk of later attention-deficit/hyperactivity disorder (ADHD), the magnitude of the risk is not well-defined. OBJECTIVE: To systematically review and meta-analyze the risk of VP/VLBW and EP/ELBW individuals to develop a ADHD categorical diagnosis or dimensional symptomatology compared with controls with normal weight and/or birth age. DATA SOURCES: We used PsycINFO, Medline, Embase, and Cochrane databases. STUDY SELECTION: We selected cross-sectional, prospective, or retrospective studies with no time or language restriction. DATA EXTRACTION: Independent reviewers screened and extracted data using predefined standard procedures. RESULTS: In 12 studies (N = 1787), researchers relying on a categorical diagnosis showed that both VP/VLBW and EP/ELBW subjects have a higher ADHD risk (odds ratio [OR] = 3.04 higher than controls; 95% confidence interval [CI] 2.19 to 4.21). In subgroup analyses, we demonstrated that the more extreme the cases, the higher the ORs (VP/VLBW: OR = 2.25 [95% CI 1.56 to 3.26]; EP/ELBW: OR = 4.05 [95% CI 2.38 to 6.87]). We drew data from 29 studies (N = 3504) on ADHD symptomatology and found significant associations with inattention (standardized mean difference [SMD] = 1.31, 95% CI 0.66 to 1.96), hyperactivity and impulsivity (SMD = 0.74, 95% CI 0.35 to 1.13), and combined symptoms (SMD = 0.55, 95% CI 0.42 to 0.68) when compared with controls. LIMITATIONS: Heterogeneity was significantly high for all analyses involving the 3 ADHD dimensions. CONCLUSIONS: With our results, we provide evidence that VP/VLBW subjects have an increased risk of ADHD diagnosis and symptomatology compared with controls, and these findings are even stronger in the EP/ELBW group. Future researchers should address which risk factors related to prematurity or low birth weight lead to ADHD.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/24932
Referências
  1. Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816
  2. American Psychiatric Association, 2013, DIAGN STAT MAN MENT
  3. Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264
  4. Anderson PJ, 2011, DEV NEUROPSYCHOL, V36, P57, DOI 10.1080/87565641.2011.540538
  5. Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50
  6. Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728
  7. Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
  8. Boyle MH, 2011, PSYCHOL MED, V41, P1763, DOI 10.1017/S0033291710002357
  9. Breeman LD, 2016, J CHILD PSYCHOL PSYC, V57, P132, DOI 10.1111/jcpp.12456
  10. Brogan E, 2014, ARCH DIS CHILD, V99, P834, DOI 10.1136/archdischild-2013-305532
  11. Burnett A, 2014, PSYCHOL MED, V44, P1533, DOI 10.1017/S0033291713002158
  12. Burnett AC, 2011, PSYCHOL MED, V41, P2463, DOI 10.1017/S003329171100081X
  13. Chang LY, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-2749
  14. Coghill D, 2005, DEVELOPMENTAL SCI, V8, P105, DOI 10.1111/j.1467-7687.2005.00397.x
  15. Conn VS, 2003, NURS RES, V52, P256, DOI 10.1097/00006199-200307000-00008
  16. Cooke RWI, 1999, ARCH DIS CHILD, V81, pF116, DOI 10.1136/fn.81.2.F116
  17. Dahl LB, 2006, PEDIATRICS, V118, pE449, DOI 10.1524/peds.2005-3021
  18. Dammann O, 2008, CLIN PERINATOL, V35, P643, DOI 10.1016/j.clp.2008.07.011
  19. de Kieviet JF, 2012, J PEDIATR-US, V161, P824, DOI 10.1016/j.jpeds.2012.05.010
  20. DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
  21. Egger M, 1997, BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
  22. Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011
  23. Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036
  24. Grunewaldt KH, 2014, EARLY HUM DEV, V90, P571, DOI 10.1016/j.earlhumdev.2014.07.005
  25. Hack M, 2004, PEDIATRICS, V114, P932, DOI 10.1542/peds.2003-1017-L
  26. Hack M, 2009, J DEV BEHAV PEDIATR, V30, P122, DOI 10.1097/DBP.0b013e31819e6a16
  27. Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007
  28. Hanke C, 2003, EUR J PEDIATR, V162, P159, DOI 10.1007/s00431-002-1127-1
  29. Hatch B, 2014, J CHILD PSYCHOL PSYC, V55, P384, DOI 10.1111/jcpp.12168
  30. Higgins J.P.T, COCHRANE HDB SYSTEMA
  31. Horwood LJ, 1998, ARCH DIS CHILD, V79, pF12, DOI 10.1136/fn.79.1.F12
  32. Huang JH, 2012, KAOHSIUNG J MED SCI, V28, P390, DOI 10.1016/j.kjms.2012.02.006
  33. Indredavik MS, 2010, J DEV BEHAV PEDIATR, V31, P286, DOI 10.1097/DBP.0b013e3181d7b1d3
  34. Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004
  35. Johnson S, 2016, J DEV BEHAV PEDIATR, V37, P285, DOI 10.1097/DBP.0000000000000298
  36. Johnson S, 2013, EARLY HUM DEV, V89, P199, DOI 10.1016/j.earlhumdev.2013.01.014
  37. Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002
  38. Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3
  39. Langley K, 2010, BRIT J PSYCHIAT, V196, P235, DOI 10.1192/bjp.bp.109.066274
  40. Leijon I, 2016, ACTA PAEDIATR, V105, P60, DOI 10.1111/apa.13094
  41. LEVYSHIFF R, 1994, J PEDIATR PSYCHOL, V19, P63, DOI 10.1093/jpepsy/19.1.63
  42. Liberati A, 2009, PLOS MED, V6, DOI [10.1016/j.jclinepi.2009.06.006, 10.1371/journal.pmed.1000100]
  43. Lindstrom K, 2009, PEDIATRICS, V123, pE47, DOI 10.1542/peds.2008-1654
  44. Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872
  45. MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813
  46. Mansson J, 2014, J DEV BEHAV PEDIATR, V35, P435, DOI 10.1097/DBP.0000000000000082
  47. McNicholas F., 2016, Irish Journal of Psychological Medicine, V33, P93, DOI 10.1017/ipm.2015.25
  48. MILLER RG, 1974, BIOMETRIKA, V61, P1
  49. Murray E, 2016, J EPIDEMIOL COMMUN H, V70, P704, DOI 10.1136/jech-2015-206222
  50. Nadeau L, 2001, J DEV BEHAV PEDIATR, V22, P1, DOI 10.1097/00004703-200102000-00001
  51. O'Shea TM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00578
  52. Perkinson-Gloor N, 2015, J PSYCHIATR RES, V60, P141, DOI 10.1016/j.jpsychires.2014.10.005
  53. Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942
  54. Polanczyk GV, 2015, J CHILD PSYCHOL PSYC, V56, P345, DOI 10.1111/jcpp.12381
  55. Rotenstein LS, 2016, JAMA-J AM MED ASSOC, V316, P2214, DOI 10.1001/jama.2016.17324
  56. Samara M, 2008, PEDIATRICS, V122, P562, DOI 10.1542/peds.2007-3231
  57. Schmucker CM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176210
  58. Schwarzer G., 2007, R NEWS, V7, P40, DOI 10.3389/FPSYG.2014.01521
  59. Scott MN, 2012, J DEV BEHAV PEDIATR, V33, P202, DOI 10.1097/DBP.0b013e3182475287
  60. Shaw M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-99
  61. Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006
  62. Simon V, 2009, BRIT J PSYCHIAT, V194, P204, DOI 10.1192/bjp.bp.107.048827
  63. Stjernqvist K, 1999, ACTA PAEDIATR, V88, P557, DOI 10.1080/08035259950169594
  64. STJERNQVIST K, 1995, ACTA PAEDIATR, V84, P500, DOI 10.1111/j.1651-2227.1995.tb13682.x
  65. Storebo OJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009885.pub2
  66. Sucksdorff M, 2015, PEDIATRICS, V136, pE599, DOI 10.1542/peds.2015-1043
  67. Sykes DH, 1997, J CHILD PSYCHOL PSYC, V38, P315, DOI 10.1111/j.1469-7610.1997.tb01516.x
  68. TB, 2004, PEDIATRICS, V114
  69. TEPLIN SW, 1991, J PEDIATR-US, V118, P768, DOI 10.1016/S0022-3476(05)80045-9
  70. Thapar A, 2016, LANCET, V387, P1240, DOI 10.1016/S0140-6736(15)00238-X
  71. Thapar A, 2012, ARCH DIS CHILD, V97, P260, DOI 10.1136/archdischild-2011-300482
  72. Torrioli MG, 2000, BRAIN DEV-JPN, V22, P163, DOI 10.1016/S0387-7604(00)00098-X
  73. Treyvaud K, 2013, J CHILD PSYCHOL PSYC, V54, P772, DOI 10.1111/jcpp.12040
  74. Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675
  75. Van Lieshout RJ, 2015, PEDIATRICS, V135, P452, DOI 10.1542/peds.2014-3143
  76. Wells G, NEWCASTLE OTTAWA SCA
  77. Woodward LJ, 2017, CLIN NEUROPSYCHOL, V31, P404, DOI 10.1080/13854046.2016.1251614

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPR
Artigos e Materiais de Revistas Científicas - LIM/39